Use este identificador para citar ou linkar para este item: https://locus.ufv.br//handle/123456789/19082
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorTeixeira, Róbson Ricardo
dc.contributor.authorGazolla, Poliana Aparecida Rodrigues
dc.contributor.authorSilva, Adalberto Manoel da
dc.contributor.authorBorsodi, Maria Paula Gonçalves
dc.contributor.authorBergmann, Bartira Rossi
dc.contributor.authorFerreira, Rafaela Salgado
dc.contributor.authorVaz, Boniek Gontijo
dc.contributor.authorVasconcelos, Géssica Adriana
dc.contributor.authorLima, Wallace Pacienza
dc.date.accessioned2018-04-24T16:45:44Z
dc.date.available2018-04-24T16:45:44Z
dc.date.issued2018-01-15
dc.identifier.issn0223-5234
dc.identifier.urihttps://doi.org/10.1016/j.ejmech.2018.01.046
dc.identifier.urihttp://www.locus.ufv.br/handle/123456789/19082
dc.description.abstractIn this paper, it is described the synthesis and the evaluation of the leishmanicidal activity of twenty-six eugenol derivatives bearing 1,2,3-triazole functionalities. The evaluation of the compounds on promastigotes of Leishmania amazonensis (WHOM/BR/75/Josefa) showed that eugenol derivatives present leishmanicidal activities with varying degrees of effectiveness. The most active compound, namely 4-(3-(4-allyl-2-methoxyphenoxy)propyl)-1-(4-methylbenzyl)-1H-1,2,3-triazole (7k) (IC50 = 7.4 ± 0.8 μmol L−1), also targeted Leishmania parasites inside peritoneal macrophages (IC50 = 1.6 μmol L−1) without interfering with cell viability. The cytotoxicity of 7k against macrophage cells presented IC50 of 211.9 μmol L−1 and the selective index was equal to 132.5. Under similar conditions, compound 7k was more effective than glucantime and pentamidine, two drugs currently in the clinic. In addition, theoretical calculations showed that this compound also presents most physicochemical and pharmacokinetic properties within the ranges expected for orally available drugs. It is believed that eugenol bearing 1,2,3-triazole functionalities may represent a scaffold to be explored toward the development of new agents to treat leishmaniasis.en
dc.formatpdfpt-BR
dc.language.isoengpt-BR
dc.publisherEuropean Journal of Medicinal Chemistrypt-BR
dc.relation.ispartofseriesv. 146, p. 274-286, February 2018pt-BR
dc.rightsElsevier Masson SASpt-BR
dc.subjectEugenolpt-BR
dc.subjectLeishmaniasispt-BR
dc.subjectAntileishmanialpt-BR
dc.subjectLeishmanicidalpt-BR
dc.subjectTriazolept-BR
dc.titleSynthesis and leishmanicidal activity of eugenol derivatives bearing 1,2,3-triazole functionalitiesen
dc.typeArtigopt-BR
Aparece nas coleções:Artigos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
artigo.pdf
  Until 2100-12-31
texto completo1,37 MBAdobe PDFVisualizar/Abrir ACESSO RESTRITO


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.